Cancer immunotherapy Authors Stefano Vella Direttore, Dipartimento del Farmaco, Istituto Superiore di Sanità, Roma - Italy DOI: https://doi.org/10.33393/grhta.2016.305 Keywords: Immunoterapia, Cancer Abstract No abstract
Downloads PDF (Italian) ePub How to Cite Vella, S. (2019). Cancer immunotherapy. Global and Regional Health Technology Assessment, 3(Suppl. 1), S1-S2. https://doi.org/10.33393/grhta.2016.305 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 3 No. Suppl. 1 (2016): Suppl. 1 - Farmaci oncologici e sostenibilità Section Editorial (on invitation only) License Copyright (c) 2019 The authors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Metrics Statistics Abstract views - 782 times PDF (Italian) downloads - 652 times ePub downloads - 321 times Sign up Browse Sections Health Technology Assessment Health Policies banners150 0.8 2023CiteScore 28th percentile Powered by Completed peer reviews since:November 4, 2020 Most popular articles in the last 30 days The societal costs associated with patients with chronic spontaneous urticaria (CSU) in Italy 461 Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs 246 Non-profit research: an insight into the management and monitoring of clinical trials in Italy 234 More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysis 220 Re-discussions in the decision process of the Italian Medicine Agency: a quantitative assessment of causes and implications 193